Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Company News

Sun's IL-23 mAb gets FDA approval for psoriasis

March 21, 2018 6:41 PM UTC

Sun Pharmaceutical Industries Ltd. (BSE:524715; NSE:SUNPHARMA) said FDA approved Ilumya tildrakizumab-asmn (MK-3222) to treat adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.

Ilumya is a humanized mAb against IL-23 subunit alpha (IL23P19; IL-23A). Sun has worldwide, ex-European rights to the drug from Merck & Co. Inc. (NYSE:MRK)...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article